FY15
Assets1,421.50
Net Worth844.90
Total Debt155.00
RevenueAnnualised basis859.90
EBITDAAnnualised basis292.80
PATAnnualised basis175.00
EBITDA Margin (%)34.05
At a glance
Updated 2026-09-02Syngene International is an IPO with an issue size of ₹550.00 crore, proposed for listing on NSE EMERGE.
Issue details
Listing atNSE EMERGE
Issue size₹550.00 Cr
Price band—–—
Grey market
GMP page ↗Latest GMPNO GMP
GMP / upper priceNO DATA
Est. listingNO DATA
GMP is unofficial sentiment data, not an exchange price.
Subscription demand
Full bidding ↗NO DATAWaiting for a verified live exchange update.
Company
Financial performance
Year-wise operating scale, profitability and balance-sheet context.Assets724.20₹ Cr · -39.2% vs prior year
Net Worth518.60₹ Cr · -21.3% vs prior year
FY14
Assets1,190.90
Net Worth659.30
Total Debt154.90
RevenueAnnualised basis699.50
EBITDAAnnualised basis222.60
PATAnnualised basis134.80
EBITDA Margin (%)31.82
FY13
Assets724.20
Net Worth518.60
Total Debt[●]
RevenueAnnualised basis550.00
EBITDAAnnualised basis172.70
PATAnnualised basis102.10
EBITDA Margin (%)31.40
Peer comparison
| Company | EPS | P/E | RoNW | NAV |
|---|---|---|---|---|
| Syngene International IPO | — | 27.00 x | — | — |
| Symbiotec Pharmalab IPO | — | 61.88 x | — | — |
| Sai Parenteral's IPO | — | 111.58 x | — | — |
| Corona Remedies IPO | — | 35.15 x | — | — |
Registrar & lead managers
Lead managers
- Location
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-09-02.
IPO UPDATE ALERTS
Register for IPO Updates →Track Syngene International without missing an update
Register for subscription, GMP, allotment and listing notifications.